Antiretroviral Therapy
Showing 1 - 25 of >10,000
HIV Infected Individuals in Assiut Governorate, Egypt
Not yet recruiting
- HIV Infections
- (no location specified)
Jul 12, 2023
HIV Transmission in Era of Scaling up Antiretroviral Therapy in
Recruiting
- HIV-1-infection
- Antiretroviral Therapy
- Exposure to antiretroviral therapy
-
Ä€dama, Oromia, EthiopiaPublic hospitals and health centers in the Adama uptake area
Dec 15, 2022
Virologically Suppressed People Living With HIV and Factors
Completed
- HIV Infections
- dual therapy
-
Tourcoing, FranceCentre Hospitalier DRON
Oct 30, 2023
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by invitation
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)
Not yet recruiting
- Refractory HIV Associated Kaposi Sarcoma
- Dostarlimab in Combination Antiretroviral Therapy
- (no location specified)
Dec 2, 2022
Gut Microbiome After Changes in Antiretroviral Therapy (ART)
Not yet recruiting
- HIV Infections
- (no location specified)
Oct 20, 2023
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
HIV, Antiretroviral Therapy Trial in New York (Heart to Heart)
Completed
- HIV
- Antiretroviral Therapy
- Heart to Heart
-
New York, New YorkNew York University College of Nursing
Oct 31, 2022
Antiretroviral Adherence and Drug-level Monitoring
Recruiting
- HIV Infections
- +4 more
-
Surabaya, East Java, IndonesiaUniversitas Airlangga Hospital
Aug 17, 2023
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023
Chronic HIV Infection Trial in Kisumu (POC VL and targeted DRM testing., SOC VL testing)
Completed
- Chronic HIV Infection
- POC VL and targeted DRM testing.
- SOC VL testing
-
Kisumu, KenyaRtcp-Faces
Dec 5, 2022
HIV-positive People, Treated With Long Acting Antiretroviral
Active, not recruiting
- HIV Infections
- Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
-
Milan, ItalyOspedale San Raffaele Scientific Institute
Dec 15, 2022
HIV Infection, Adherence, Medication, Adherence, Treatment Trial in Boston (Next-generation Reader and ID-Cap System, Truvada
Recruiting
- HIV Infection
- +4 more
- Next-generation Reader and ID-Cap System
- +2 more
-
Boston, MassachusettsFenway Health
Dec 20, 2022
HIV-1-infection, Antenatal Care Trial in Lilongwe (iNSC and Adherence supporter training)
Completed
- HIV-1-infection
- Antenatal Care
- iNSC and Adherence supporter training
-
Lilongwe, MalawiBwaila District Hospital
Jan 9, 2023
HIV, Hiv Trial (Community Antiretroviral Therapy)
Not yet recruiting
- HIV Infections
- Hiv
- Community Antiretroviral Therapy
- (no location specified)
Nov 6, 2023
HIV Positive Trial in Saint-etienne (blood and urinary samples)
Not yet recruiting
- HIV Positive
- blood and urinary samples
-
Saint-etienne, FranceChu Saint-Etienne
Nov 29, 2022
HIV-1-infection Trial in Chapel Hill (MGD014)
Completed
- HIV-1-infection
- MGD014
-
Chapel Hill, North CarolinaUniversity of North Carolina Chapel Hill
Aug 31, 2022
HIV, Cannabis Use Trial in San Diego (THC Cannabis, CBD Cannabis, Placebo)
Recruiting
- HIV
- Cannabis Use
- THC Cannabis
- +2 more
-
San Diego, CaliforniaUcsd Hnrp-Cmcr
Aug 23, 2022
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022